• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: PD

ECG abnormalities may be PD risk factor

July 6, 2011  

First report of increased risk of prostate cancer in PD

June 29, 2011  

NMDA antagonists in Parkinson’s disease: meta-analysis

June 29, 2011  

Deep brain stimulation: consensus recommendations

March 9, 2011  

MoCA recommended to detect cognitive dysfunction in Parkinson’s disease

February 23, 2011  

Parkinson’s disease and melanoma: no genetic link

February 9, 2011  

Trial of pramipexole for depression in PD

December 8, 2010  

SCT in Parkinson’s disease

September 15, 2010  

Treatment of nonmotor symptoms: AAN report

September 1, 2010  

Trichloroethylene associated with PD risk

July 7, 2010  
Previous
3
4
5
6
7
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • McDonald criteria 2024: what changes can we expect? posted on January 30, 2024
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions